A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tenofovir Impurity 34 - Request Quote

Picture of Tenofovir Impurity 34

Tenofovir Impurity 34

SZ CAT No:SZ-T012037
CAS No
NA
Mol.F.
C17H28N5O7P : C4H4O4
Mol.Wt.
445.4 : 116.1
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Tenofovir Impurity 34 is chemically ((((((S)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(isopropoxy)phosphoryl)oxy)methyl isopropyl carbonate fumarate. Tenofovir Impurity 34 is supplied with detailed characterization data compliant with regulatory guideline. Tenofovir Impurity 34 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tenofovir.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Tenofovir Impurity 34

Purchase Tenofovir Impurity 34

Tenofovir Impurity 34 suppliers

Tenofovir Impurity 34 manufacturers

Tenofovir Impurity 34 price

Order Tenofovir Impurity 34

Enquire Tenofovir Impurity 34

Tenofovir Impurity 34 cost

Tenofovir Impurity 34 Supplier

Tenofovir Impurity 34 Distributor

Tenofovir Impurity 34 for Method Validation

Tenofovir Reference Standard

Tenofovir Impurity 34 for ANDA Filing

Tenofovir Impurity 34 for Forced Degradation Studies

Tenofovir Impurity 34 Identification Standards

Tenofovir Impurity 34 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,